Global Frovatriptan Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Frovatriptan will have significant change from previous year. By the most conservative estimates of global Frovatriptan market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Frovatriptan market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Frovatriptan market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Frovatriptan, covering the supply chain analysis, impact assessment to the Frovatriptan market size growth rate in several scenarios, and the measures to be undertaken by Frovatriptan companies in response to the COVID-19 epidemic.
Segmentation by access channel: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hospital
Drug Store
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Menstrual Migraines
Migraine with Aura
Migraine without Aura
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ligand Pharmaceuticals
Apotex
Endo Pharmaceuticals
Menarini
Novartis
Doc Generici
Teva
Almac
Zambon
Glenmark Generics
G.L. Pharma
Chanelle Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Frovatriptan consumption (value & volume) by key regions/countries, access channel and medical uses, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Frovatriptan market by identifying its various subsegments.
Focuses on the key global Frovatriptan manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Frovatriptan with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Frovatriptan submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Frovatriptan?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Frovatriptan Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Frovatriptan Consumption 2015-2025
2.1.2 Frovatriptan Consumption CAGR by Region
2.2 Frovatriptan Segment by Access Channel
2.2.1 Hospital
2.2.2 Drug Store
2.3 Frovatriptan Consumption by Access Channel
2.3.1 Global Frovatriptan Consumption Market Share by Access Channel (2015-2020)
2.3.2 Global Frovatriptan Revenue and Market Share by Access Channel (2015-2020)
2.3.3 Global Frovatriptan Sale Price by Access Channel (2015-2020)
2.4 Frovatriptan Segment by Medical Uses
2.4.1 Menstrual Migraines
2.4.2 Migraine with Aura
2.4.3 Migraine without Aura
2.5 Frovatriptan Consumption by Medical Uses
2.5.1 Global Frovatriptan Consumption Market Share by Access Channel (2015-2020)
2.5.2 Global Frovatriptan Value and Market Share by Access Channel (2015-2020)
2.5.3 Global Frovatriptan Sale Price by Access Channel (2015-2020)
3 Global Frovatriptan by Company
3.1 Global Frovatriptan Sales Market Share by Company
3.1.1 Global Frovatriptan Sales by Company (2018-2020)
3.1.2 Global Frovatriptan Sales Market Share by Company (2018-2020)
3.2 Global Frovatriptan Revenue Market Share by Company
3.2.1 Global Frovatriptan Revenue by Company (2018-2020)
3.2.2 Global Frovatriptan Revenue Market Share by Company (2018-2020)
3.3 Global Frovatriptan Sale Price by Company
3.4 Global Frovatriptan Manufacturing Base Distribution, Sales Area, Access Channel by Company
3.4.1 Global Frovatriptan Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Frovatriptan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Frovatriptan by Regions
4.1 Frovatriptan by Regions
4.2 Americas Frovatriptan Consumption Growth
4.3 APAC Frovatriptan Consumption Growth
4.4 Europe Frovatriptan Consumption Growth
4.5 Middle East & Africa Frovatriptan Consumption Growth
5 Americas
5.1 Americas Frovatriptan Consumption by Countries
5.1.1 Americas Frovatriptan Consumption by Countries (2015-2020)
5.1.2 Americas Frovatriptan Value by Countries (2015-2020)
5.2 Americas Frovatriptan Consumption by Access Channel
5.3 Americas Frovatriptan Consumption by Medical Uses
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Frovatriptan Consumption by Regions
6.1.1 APAC Frovatriptan Consumption by Regions (2015-2020)
6.1.2 APAC Frovatriptan Value by Regions (2015-2020)
6.2 APAC Frovatriptan Consumption by Access Channel
6.3 APAC Frovatriptan Consumption by Medical Uses
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Frovatriptan by Countries
7.1.1 Europe Frovatriptan Consumption by Countries (2015-2020)
7.1.2 Europe Frovatriptan Value by Countries (2015-2020)
7.2 Europe Frovatriptan Consumption by Access Channel
7.3 Europe Frovatriptan Consumption by Medical Uses
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Frovatriptan by Countries
8.1.1 Middle East & Africa Frovatriptan Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Frovatriptan Value by Countries (2015-2020)
8.2 Middle East & Africa Frovatriptan Consumption by Access Channel
8.3 Middle East & Africa Frovatriptan Consumption by Medical Uses
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Frovatriptan Distributors
10.3 Frovatriptan Customer
11 Global Frovatriptan Market Forecast
11.1 Global Frovatriptan Consumption Forecast (2021-2025)
11.2 Global Frovatriptan Forecast by Regions
11.2.1 Global Frovatriptan Forecast by Regions (2021-2025)
11.2.2 Global Frovatriptan Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Frovatriptan Forecast by Access Channel
11.8 Global Frovatriptan Forecast by Medical Uses
12 Key Players Analysis
12.1 Ligand Pharmaceuticals
12.1.1 Company Information
12.1.2 Frovatriptan Product Offered
12.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Ligand Pharmaceuticals Latest Developments
12.2 Apotex
12.2.1 Company Information
12.2.2 Frovatriptan Product Offered
12.2.3 Apotex Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Apotex Latest Developments
12.3 Endo Pharmaceuticals
12.3.1 Company Information
12.3.2 Frovatriptan Product Offered
12.3.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Endo Pharmaceuticals Latest Developments
12.4 Menarini
12.4.1 Company Information
12.4.2 Frovatriptan Product Offered
12.4.3 Menarini Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Menarini Latest Developments
12.5 Novartis
12.5.1 Company Information
12.5.2 Frovatriptan Product Offered
12.5.3 Novartis Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Doc Generici
12.6.1 Company Information
12.6.2 Frovatriptan Product Offered
12.6.3 Doc Generici Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Doc Generici Latest Developments
12.7 Teva
12.7.1 Company Information
12.7.2 Frovatriptan Product Offered
12.7.3 Teva Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Teva Latest Developments
12.8 Almac
12.8.1 Company Information
12.8.2 Frovatriptan Product Offered
12.8.3 Almac Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Almac Latest Developments
12.9 Zambon
12.9.1 Company Information
12.9.2 Frovatriptan Product Offered
12.9.3 Zambon Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Zambon Latest Developments
12.10 Glenmark Generics
12.10.1 Company Information
12.10.2 Frovatriptan Product Offered
12.10.3 Glenmark Generics Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Glenmark Generics Latest Developments
12.11 G.L. Pharma
12.11.1 Company Information
12.11.2 Frovatriptan Product Offered
12.11.3 G.L. Pharma Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 G.L. Pharma Latest Developments
12.12 Chanelle Pharma
12.12.1 Company Information
12.12.2 Frovatriptan Product Offered
12.12.3 Chanelle Pharma Frovatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Chanelle Pharma Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Frovatriptan Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Frovatriptan Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Frovatriptan Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Hospital
Table 7. Major Players of Drug Store
Table 8. Global Consumption Sales by Access Channel (2015-2020)
Table 9. Global Frovatriptan Consumption Market Share by Access Channel (2015-2020)
Table 10. Global Frovatriptan Revenue by Access Channel (2015-2020) ($ million)
Table 11. Global Frovatriptan Value Market Share by Access Channel (2015-2020) ($ Millions)
Table 12. Global Frovatriptan Sale Price by Access Channel (2015-2020)
Table 13. Global Consumption Sales by Medical Uses (2015-2020)
Table 14. Global Frovatriptan Consumption Market Share by Medical Uses (2015-2020)
Table 15. Global Frovatriptan Value by Medical Uses (2015-2020)
Table 16. Global Frovatriptan Value Market Share by Medical Uses (2015-2020)
Table 17. Global Frovatriptan Sale Price by Medical Uses (2015-2020)
Table 18. Global Frovatriptan Sales by Company (2017-2019) (K Units)
Table 19. Global Frovatriptan Sales Market Share by Company (2017-2019)
Table 20. Global Frovatriptan Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Frovatriptan Revenue Market Share by Company (2017-2019)
Table 22. Global Frovatriptan Sale Price by Company (2017-2019)
Table 23. Global Frovatriptan Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Frovatriptan Products Offered
Table 25. Frovatriptan Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Frovatriptan Consumption by Regions 2015-2020 (K Units)
Table 27. Global Frovatriptan Consumption Market Share by Regions 2015-2020
Table 28. Global Frovatriptan Value by Regions 2015-2020 ($ Millions)
Table 29. Global Frovatriptan Value Market Share by Regions 2015-2020
Table 30. Americas Frovatriptan Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Frovatriptan Consumption Market Share by Countries (2015-2020)
Table 32. Americas Frovatriptan Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Frovatriptan Value Market Share by Countries (2015-2020)
Table 34. Americas Frovatriptan Consumption by Type (2015-2020) (K Units)
Table 35. Americas Frovatriptan Consumption Market Share by Access Channel (2015-2020)
Table 36. Americas Frovatriptan Consumption by Medical Uses (2015-2020) (K Units)
Table 37. Americas Frovatriptan Consumption Market Share by Medical Uses (2015-2020)
Table 38. APAC Frovatriptan Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Frovatriptan Consumption Market Share by Countries (2015-2020)
Table 40. APAC Frovatriptan Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Frovatriptan Value Market Share by Regions (2015-2020)
Table 42. APAC Frovatriptan Consumption by Access Channel (2015-2020) (K Units)
Table 43. APAC Frovatriptan Consumption Market Share by Access Channel (2015-2020)
Table 44. APAC Frovatriptan Consumption by Medical Uses (2015-2020) (K Units)
Table 45. APAC Frovatriptan Consumption Market Share by Medical Uses (2015-2020)
Table 46. Europe Frovatriptan Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Frovatriptan Consumption Market Share by Countries (2015-2020)
Table 48. Europe Frovatriptan Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Frovatriptan Value Market Share by Countries (2015-2020)
Table 50. Europe Frovatriptan Consumption by Type (2015-2020) (K Units)
Table 51. Europe Frovatriptan Consumption Market Share by Access Channel (2015-2020)
Table 52. Europe Frovatriptan Consumption by Medical Uses (2015-2020) (K Units)
Table 53. Europe Frovatriptan Consumption Market Share by Medical Uses (2015-2020)
Table 54. Middle East & Africa Frovatriptan Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Frovatriptan Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Frovatriptan Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Frovatriptan Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Frovatriptan Consumption by Access Channel (2015-2020) (K Units)
Table 59. Middle East & Africa Frovatriptan Consumption Market Share by Access Channel (2015-2020)
Table 60. Middle East & Africa Frovatriptan Consumption by Medical Uses (2015-2020) (K Units)
Table 61. Middle East & Africa Frovatriptan Consumption Market Share by Medical Uses (2015-2020)
Table 62. Frovatriptan Distributors List
Table 63. Frovatriptan Customer List
Table 64. Global Frovatriptan Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Frovatriptan Consumption Market Forecast by Regions
Table 66. Global Frovatriptan Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Frovatriptan Value Market Share Forecast by Regions
Table 68. Global Frovatriptan Consumption Forecast by Access Channel (2021-2025) (K Units)
Table 69. Global Frovatriptan Consumption Market Share Forecast by Access Channel (2021-2025)
Table 70. Global Frovatriptan Value Forecast by Access Channel (2021-2025) ($ Millions)
Table 71. Global Frovatriptan Value Market Share Forecast by Access Channel (2021-2025)
Table 72. Global Frovatriptan Consumption Forecast by Medical Uses (2021-2025) (K Units)
Table 73. Global Frovatriptan Consumption Market Share Forecast by Medical Uses (2021-2025)
Table 74. Global Frovatriptan Value Forecast by Medical Uses (2021-2025) ($ Millions)
Table 75. Global Frovatriptan Value Market Share Forecast by Medical Uses (2021-2025)
Table 76. Ligand Pharmaceuticals Product Offered
Table 77. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Ligand Pharmaceuticals Main Business
Table 79. Ligand Pharmaceuticals Latest Developments
Table 80. Ligand Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 81. Apotex Product Offered
Table 82. Apotex Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Apotex Main Business
Table 84. Apotex Latest Developments
Table 85. Apotex Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 86. Endo Pharmaceuticals Product Offered
Table 87. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Endo Pharmaceuticals Main Business
Table 89. Endo Pharmaceuticals Latest Developments
Table 90. Endo Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 91. Menarini Product Offered
Table 92. Menarini Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Menarini Main Business
Table 94. Menarini Latest Developments
Table 95. Menarini Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Product Offered
Table 97. Novartis Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Novartis Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 101. Doc Generici Product Offered
Table 102. Doc Generici Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Doc Generici Main Business
Table 104. Doc Generici Latest Developments
Table 105. Doc Generici Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Product Offered
Table 107. Teva Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 108. Teva Main Business
Table 109. Teva Latest Developments
Table 110. Teva Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Almac Product Offered
Table 112. Almac Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Almac Main Business
Table 114. Almac Latest Developments
Table 115. Almac Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 116. Zambon Product Offered
Table 117. Zambon Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Zambon Main Business
Table 119. Zambon Latest Developments
Table 120. Zambon Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 121. Glenmark Generics Product Offered
Table 122. Glenmark Generics Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Glenmark Generics Main Business
Table 124. Glenmark Generics Latest Developments
Table 125. Glenmark Generics Basic Information, Company Total Revenue (in $ million), Frovatriptan Manufacturing Base, Sales Area and Its Competitors
Table 126. G.L. Pharma Product Offered
Table 127. G.L. Pharma Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. G.L. Pharma Main Business
Table 129. G.L. Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. G.L. Pharma Latest Developments
Table 131. Chanelle Pharma Product Offered
Table 132. Chanelle Pharma Frovatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Chanelle Pharma Main Business
Table 134. Chanelle Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Chanelle Pharma Latest Developments
List of Figures
Figure 1. Picture of Frovatriptan
Figure 2. Frovatriptan Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Frovatriptan Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Frovatriptan Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hospital
Figure 7. Product Picture of Drug Store
Figure 8. Global Frovatriptan Consumption Market Share by Access Channel (2015-2020)
Figure 9. Global Frovatriptan Value Market Share by Access Channel (2015-2020)
Figure 10. Frovatriptan Consumed in Menstrual Migraines
Figure 11. Global Frovatriptan Market: Menstrual Migraines (2015-2020) (K Units)
Figure 12. Global Frovatriptan Market: Menstrual Migraines (2015-2020) ($ Millions)
Figure 13. Frovatriptan Consumed in Migraine with Aura
Figure 14. Global Frovatriptan Market: Migraine with Aura (2015-2020) (K Units)
Figure 15. Global Frovatriptan Market: Migraine with Aura (2015-2020) ($ Millions)
Figure 16. Frovatriptan Consumed in Migraine without Aura
Figure 17. Global Frovatriptan Market: Migraine without Aura (2015-2020) (K Units)
Figure 18. Global Frovatriptan Market: Migraine without Aura (2015-2020) ($ Millions)
Figure 19. Global Frovatriptan Consumption Market Share by Medical Uses (2015-2020)
Figure 20. Global Frovatriptan Value Market Share by Medical Uses (2015-2020)
Figure 21. Global Frovatriptan Sales Market Share by Company in 2017
Figure 22. Global Frovatriptan Sales Market Share by Company in 2019
Figure 23. Global Frovatriptan Revenue Market Share by Company in 2017
Figure 24. Global Frovatriptan Revenue Market Share by Company in 2019
Figure 25. Global Frovatriptan Sale Price by Company in 2019
Figure 26. Global Frovatriptan Consumption Market Share by Regions 2015-2020
Figure 27. Global Frovatriptan Value Market Share by Regions 2015-2020
Figure 28. Americas Frovatriptan Consumption 2015-2020 (K Units)
Figure 29. Americas Frovatriptan Value 2015-2020 ($ Millions)
Figure 30. APAC Frovatriptan Consumption 2015-2020 (K Units)
Figure 31. APAC Frovatriptan Value 2015-2020 ($ Millions)
Figure 32. Europe Frovatriptan Consumption 2015-2020 (K Units)
Figure 33. Europe Frovatriptan Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Frovatriptan Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Frovatriptan Value 2015-2020 ($ Millions)
Figure 36. Americas Frovatriptan Consumption Market Share by Countries in 2019
Figure 37. Americas Frovatriptan Value Market Share by Countries in 2019
Figure 38. Americas Frovatriptan Consumption Market Share by Access Channel in 2019
Figure 39. Americas Frovatriptan Consumption Market Share by Medical Uses in 2019
Figure 40. United States Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 41. United States Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Frovatriptan Consumption Market Share by Countries in 2019
Figure 47. APAC Frovatriptan Value Market Share by Regions in 2019
Figure 48. APAC Frovatriptan Consumption Market Share by Access Channel in 2019
Figure 49. APAC Frovatriptan Consumption Market Share by Medical Uses in 2019
Figure 50. China Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 51. China Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 58. India Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 59. India Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Frovatriptan Consumption Market Share by Countries in 2019
Figure 63. Europe Frovatriptan Value Market Share by Countries in 2019
Figure 64. Europe Frovatriptan Consumption Market Share by Access Channel in 2019
Figure 65. Europe Frovatriptan Consumption Market Share by Medical Uses in 2019
Figure 66. Germany Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 68. France Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 69. France Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 70. UK Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 71. UK Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Frovatriptan Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Frovatriptan Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Frovatriptan Consumption Market Share by Access Channel in 2019
Figure 79. Middle East & Africa Frovatriptan Consumption Market Share by Medical Uses in 2019
Figure 80. Egypt Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Frovatriptan Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Frovatriptan Value Growth 2015-2020 ($ Millions)
Figure 90. Global Frovatriptan Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Frovatriptan Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Frovatriptan Consumption 2021-2025 (K Units)
Figure 93. Americas Frovatriptan Value 2021-2025 ($ Millions)
Figure 94. APAC Frovatriptan Consumption 2021-2025 (K Units)
Figure 95. APAC Frovatriptan Value 2021-2025 ($ Millions)
Figure 96. Europe Frovatriptan Consumption 2021-2025 (K Units)
Figure 97. Europe Frovatriptan Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Frovatriptan Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Frovatriptan Value 2021-2025 ($ Millions)
Figure 100. United States Frovatriptan Consumption 2021-2025 (K Units)
Figure 101. United States Frovatriptan Value 2021-2025 ($ Millions)
Figure 102. Canada Frovatriptan Consumption 2021-2025 (K Units)
Figure 103. Canada Frovatriptan Value 2021-2025 ($ Millions)
Figure 104. Mexico Frovatriptan Consumption 2021-2025 (K Units)
Figure 105. Mexico Frovatriptan Value 2021-2025 ($ Millions)
Figure 106. Brazil Frovatriptan Consumption 2021-2025 (K Units)
Figure 107. Brazil Frovatriptan Value 2021-2025 ($ Millions)
Figure 108. China Frovatriptan Consumption 2021-2025 (K Units)
Figure 109. China Frovatriptan Value 2021-2025 ($ Millions)
Figure 110. Japan Frovatriptan Consumption 2021-2025 (K Units)
Figure 111. Japan Frovatriptan Value 2021-2025 ($ Millions)
Figure 112. Korea Frovatriptan Consumption 2021-2025 (K Units)
Figure 113. Korea Frovatriptan Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Frovatriptan Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Frovatriptan Value 2021-2025 ($ Millions)
Figure 116. India Frovatriptan Consumption 2021-2025 (K Units)
Figure 117. India Frovatriptan Value 2021-2025 ($ Millions)
Figure 118. Australia Frovatriptan Consumption 2021-2025 (K Units)
Figure 119. Australia Frovatriptan Value 2021-2025 ($ Millions)
Figure 120. Germany Frovatriptan Consumption 2021-2025 (K Units)
Figure 121. Germany Frovatriptan Value 2021-2025 ($ Millions)
Figure 122. France Frovatriptan Consumption 2021-2025 (K Units)
Figure 123. France Frovatriptan Value 2021-2025 ($ Millions)
Figure 124. UK Frovatriptan Consumption 2021-2025 (K Units)
Figure 125. UK Frovatriptan Value 2021-2025 ($ Millions)
Figure 126. Italy Frovatriptan Consumption 2021-2025 (K Units)
Figure 127. Italy Frovatriptan Value 2021-2025 ($ Millions)
Figure 128. Russia Frovatriptan Consumption 2021-2025 (K Units)
Figure 129. Russia Frovatriptan Value 2021-2025 ($ Millions)
Figure 130. Spain Frovatriptan Consumption 2021-2025 (K Units)
Figure 131. Spain Frovatriptan Value 2021-2025 ($ Millions)
Figure 132. Egypt Frovatriptan Consumption 2021-2025 (K Units)
Figure 133. Egypt Frovatriptan Value 2021-2025 ($ Millions)
Figure 134. South Africa Frovatriptan Consumption 2021-2025 (K Units)
Figure 135. South Africa Frovatriptan Value 2021-2025 ($ Millions)
Figure 136. Israel Frovatriptan Consumption 2021-2025 (K Units)
Figure 137. Israel Frovatriptan Value 2021-2025 ($ Millions)
Figure 138. Turkey Frovatriptan Consumption 2021-2025 (K Units)
Figure 139. Turkey Frovatriptan Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Frovatriptan Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Frovatriptan Value 2021-2025 ($ Millions)
Figure 142. Ligand Pharmaceuticals Frovatriptan Market Share (2018-2020)
Figure 143. Apotex Frovatriptan Market Share (2018-2020)
Figure 144. Endo Pharmaceuticals Frovatriptan Market Share (2018-2020)
Figure 145. Menarini Frovatriptan Market Share (2018-2020)
Figure 146. Novartis Frovatriptan Market Share (2018-2020)
Figure 147. Doc Generici Frovatriptan Market Share (2018-2020)
Figure 148. Teva Frovatriptan Market Share (2018-2020)
Figure 149. Almac Frovatriptan Market Share (2018-2020)
Figure 150. Zambon Frovatriptan Market Share (2018-2020)
Figure 151. Glenmark Generics Frovatriptan Market Share (2018-2020)
Figure 152. G.L. Pharma Frovatriptan Market Share (2018-2020)
Figure 153. Chanelle Pharma Frovatriptan Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets